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Summary
Objective: Interleukin-1b (IL-1b) stimulates collagenase-1 (Matrix Metalloproteinase-1 (MMP-1)) expression in articular chondrocytes, leading
to cleavage of type II collagen and irreversible cartilage degradation. The nuclear factor-kappa B (NF-kB) pathway is potently activated in
IL-1b-stimulated cells and has been implicated as an intermediate in MMP-1 gene expression. However, the roles of individual NF-kB family
members during IL-1b-induced MMP-1 gene expression have not been deﬁned.
Results: To address the relationship between the NF-kB pathway andMMP-1 gene activation in chondrocytes, primary cultured human articular
chondrocyte cultures (HAC) and SW-1353 cells were stimulated with IL-1b over a 24-h time course andMMP-1, NF-kB1, NF-kB2 and RelA gene
expression was assayed. IL-1b-induced MMP-1 expression was comparable in HAC and SW-1353 cells both temporally and quantitatively.
MMP-1 gene expression was mirrored by increases in NF-kB gene expression, and inhibition of NF-kB nuclear translocation with dominant-
negative IkBa reduced IL-1b-dependent MMP-1 gene expression. IL-1b activated the NF-kB pathway in chondrocytes, both through phosphor-
ylation and transient degradation of IkBa, as well as through sustained phosphorylation of RelA. Small inhibitory RNAs (siRNA) speciﬁc for RelA
resulted in signiﬁcant reduction of MMP-1 mRNA, whereas siRNA for NF-kB1 and NF-kB2 augmented IL-1b-induced MMP-1 expression.
Conclusions: Our data demonstrate that IL-1b activation of the NF-kB pathway is required for IL-1b induction of MMP-1 in chondrocytes and
that RelA can work independently of NF-kB1 or NF-kB2 to activate this gene expression program.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Rheumatoid arthritis (RA) and osteoarthritis (OA) have
distinct etiologies, yet both diseases result in the permanent
destruction of articular cartilage. Articular cartilage consists
primarily of the matrix proteins type II collagen and aggre-
can. In RA and OA, the Matrix Metalloproteinases (MMPs)
degrade the collagen present in the cartilage, while
members of the A Disintegrin And Metalloproteinase with
ThromboSpondin motifs (ADAMTS) family target aggrecan.
Although digestion of aggrecan can be transient, cleavage
of type II collagen is believed to be the committed step for
irreversible cartilage degradation1. There are four MMPs
family members that are interstitial collagenases, including
collagenase-1 (MMP-1), collagenase-2 (MMP-8), collage-
nase-3 (MMP-13) and membrane-type-1 MMP (MMP-
14)2,3. MMP-14 is expressed in RA synovium, while
MMP-1, MMP-8 and MMP-13 are expressed in both syno-
vium and cartilage of RA and OA patients4e9. The
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and MMP-13 expression in articular chondrocytes7,8 and
this correlates with cartilage loss in arthritic lesions7,10,11.
MMP-1 and MMP-13 are both expressed in cartilage lesions
that form before the onset of clinical disease10, suggesting
that both enzymes are important for disease initiation. While
MMP-13 degrades resident collagen ﬁbrils in the cartilage,
MMP-1 may be more important for remodeling of newly
synthesized collagen12. Thus, elucidating how cytokines
like IL-1b activate MMP-1 gene expression in chondrocytes
is critical for understanding the pathogenesis of arthritis.
The nuclear factor-kappa B (NF-kB) pathway is an impor-
tant mediator of cyotkine-induced gene expression in
inﬂammation and immunity. The NF-kB family of transcrip-
tion factors consists of NF-kB1, NF-kB2, RelA, c-Rel and
RelB. NF-kB1 and NF-kB2 are synthesized as propeptides
that contain a Rel homology domain involved in DNA bind-
ing activity and nuclear localization, and an ankyrin-rich
cytoplasmic domain that sequesters these proteins in the
cytoplasm. During translation (NF-kB1) or in response to
signal-dependent phosphorylation (NF-kB2), the cytoplas-
mic domains are proteolytically removed and these proteins
translocate to the nucleus13. Both NF-kB1 and NF-kB2 lack
transactivation domains and must dimerize with Rel family
members to create transcriptionally competent complexes.
RelA forms heterodimers with processed NF-kB1 or1
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inhibitor of kappa B (IkB)14. Following cellular stimulation
with cytokines, IkB is phosphorylated by the IkB kinases
(IKK) and degraded by the proteosome, resulting in nuclear
translocation of RelA complexes. RelA can also be released
from IkB repression by direct phosphorylation on serine
536, and in this phosphorylated state, RelA does not asso-
ciate with NF-kB115. Thus, cytokine stimulation results in
a complex NF-kB activation program that can impact
MMP-1 gene expression.
IL-1b activation of theMMP-1 gene requires the integration
of several signaling pathways and activated transcription fac-
tors16. Recent work in our laboratory has demonstrated that
IL-1b stimulates MMP-1 transcription in chondrocytes
through extracellular signal-regulated kinase (ERK)-depen-
dent activation of CCAAT enhancer binding protein-beta
(C/EBPb)17. In addition to the ERK pathway, IL-1b activation
of the NF-kB pathway contributes to increased MMP-1 gene
expression in synovial ﬁbroblasts and vascular smooth mus-
cle cells18,19. However, there have been conﬂicting reports
regarding the importance of NF-kB during MMP-1 expres-
sion in chondrocytic cells. Bondeson et al.20 reported that
over expression of wild type IkBa reduced MMP-1 gene ex-
pression, while Mengshol et al.21 found that a dominant neg-
ative allele of this gene had no effect on MMP-1. Work in our
laboratory has demonstrated that IL-1b elevated NF-kB and
MMP-1 gene expression in SW-1353 chondrosarcoma
cells22,23. Gebauer et al. recently conﬁrmed this correlation
between NF-kB and MMP-1 gene expression24, and these
authors concluded that the SW-1353 cell line is an appropri-
ate model of IL-1b-induced MMP-1 and NF-kB gene expres-
sion in human articular chondrocytes.
In the present study, we set out to determine if there is
a mechanistic link between IL-1b induction of the NF-kB
pathway, and IL-1b induction of MMP-1 gene expression in
chondrocytes. We found a temporal correlation between
IL-1b-stimulated NF-kB and MMP-1 gene activation and
that dominant-negative IkBa (IKBDN) repressed IL-1b-
dependent MMP-1 expression. While IL-1b stimulates a
transient phosphorylation and degradation of IkBa in chon-
drocytes, RelA phosphorylation on serine 536 is more sus-
tained. Moreover, of the NF-kB genes assayed, only RelA
was found to be required for IL-1b-induced MMP-1 gene ex-
pression. These data provide a new model of NF-kB-depen-
dent MMP-1 gene expression in chondrocytes, which
involves heterodimer-independent mechanisms.
Methods and Materials
CELL CULTURE AND REAGENTS
SW-1353 cells were purchased from ATCC and cultured
in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) supple-
mented with 10% FBS (Hyclone, Logan, UT), penicillin/
streptomycin, and glutamine (Cellgro, Mediatech, Herndon,
VA). Cultured human articular chondrocyte (HAC) were
prepared as previously described25. For assays of gene
expression, cells were washed with HBSS and placed in
DMEM supplemented with 0.2% lactalbumin hydrolyzate
(Invitrogen, Carlsbad, CA). Recombinant human IL-1b
was purchased from Promega (Madison, WI).
ANALYSIS OF STEADY STATE mRNA
Analysis of gene expression was performed by quan-
titative reverse transcriptase polymerase chain reaction(QRT-PCR) as described previously22,25. The following
primers were used to amplify reverse-transcribed mRNA.
RelA: 50-CTGCCGGGATGGCTTCTAT-30
50-CCGCTTCTTCACACACTGGAT-30
NF-kB1: 50-TGGAGTCTGGGAAGGATTT-30
50-CGAAGCTGGACAAACACAG-30
NF-kB2: 50-GCGCAGGACGAGAACGGAGAC-30
50-TGGGCGTGGTGGATGACATA-30
MMP-1: 50-AGCTAGCTCAGGATGACATTGATG-30
50-GCCGATGGGCTGGACAG-30
GAPDH: 50-CGACAGTCAGCCGCATCTT-30
50-CCCCATGGTGTCTGAGCG-30
TRANSFECTION AND CREATION OF STABLE CELL LINES
SW-1353 cells were transfected with an empty vector or
a plasmid expressing an HA-tagged IKBDN (Biomyx Tech-
nology, San Diego, CA) using the Nucleofector transfection
system (Amaxa Inc. Gaithersburg, MD) according to the
manufacturer0s protocol. Transfectants were placed under
selection with Geneticin (Invitrogen Carlsbad, CA) and
pooled stable lines were established. IKBDN transgene
expression was conﬁrmed by Western blot using an HA an-
tibody (data not shown). In order to conﬁrm the functionality
of the IKBDN transgene, the stable line was transiently
transfected in triplicate with a kappa B luciferase reporter
gene (Stratagene, La Jolla, CA) and assayed using Lucifer-
ase Assay Reagent (Promega Corporation, Madison, WI).
Triplicate cultures of this stable line were also assayed for
MMP-1 and GAPDH gene expression by QRT-PCR as de-
scribed above.
In separate experiments, SW-1353 were transfected with
a 3292 nucleotide human MMP-1 promoter/luciferase
reporter plasmid26 along with a plasmid containing the neo-
mycin gene. Transfectants were placed under selection with
Geneticin (Invitrogen Carlsbad, CA) and pooled stable lines
were established. This stable line was plated in triplicate
and assayed using Luciferase Assay Reagent (Promega
Corporation, Madison, WI).
WESTERN BLOT
Conﬂuent monolayers of HAC were stimulated as indi-
cated, washed brieﬂy in phosphate buffered saline and
then scraped into 2 laemmli buffer. The samples were
heated to 100C for 5 min and then run on 10% reducing
SDS-PAGE gels. The proteins were transferred to PVDF
membranes (Millipore, Bedford, MA) and probed using com-
mercially available antibodies for NF-kB1 (Santa Cruz
Biotechnology, Santa Cruz, CA, SC-114), NF-kB2 (Upstate
Cell Signaling Solutions, Charlottesville, VA, 06-413), RelA
(Santa Cruz Biotechnology, SC-109), RelA phospho-serine
536 (Cell Signaling Technology, Danvers, MA, #3031), IkBa
(Cell Signaling Technology, #9242), IkBa phospho-serine
32 (Cell Signaling Technology #9241) and Pan Actin (Cell
Signaling Technology #4968). Blots were visualized using
the Pierce Biotechnology (Rockford, IL) Supersignal West
Femto detection kit.
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The following double-stranded siRNAs were designed us-
ing Oligoengine software and purchased from Dharmacon
Research, Inc. (Lafayette, CO).
RelA: 50-UCCAGUGUGUGAAGAAGCGdTdT-30
30-dTdTAGGUCACACACUUCUUCGC-50
NF-kB1: 50-CACUGGAAGCACGAAUGACdTdT-30
30-dTdTGUGACCUUCGUGCUUACUG-50
NF-kB2: 50-GAUUUCUCGAAUGGACAAGdTdT-30
30-dTdTCUAAAGAFCUUACCUGUUC-50
Control: 50-AGAGAUGCAUGCACGCACAdTdT-30
30-dTdTUCUCUACGUACGUGCGUGU-50
For siRNA experiments, SW-1353 cells were transfected
with siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. HAC were
transfected using the Nucleofector transfection system
(Amaxa Inc. Gaithersburg, MD) according to the manufac-
turer’s protocol. After 48 h of culture, cells were washed,
placed in DMEM supplemented with LH, with or without
IL-1b (10 ng/ml). After 24 h of culture, RNA was harvested
with TRIzol reagent (Invitrogen, Carlsbad, CA) for gene ex-
pression analysis.
STATISTICAL ANALYSIS
Data are presented as means of triplicate cultures with
standard deviations. Statistical signiﬁcance was assessed
by two-tailed Student’s t test. Unless otherwise indicated,
* indicates P 0.05.
Results
IL-1b ACTIVATES MMP-1 AND NF-kB GENE
EXPRESSION IN CHONDROCYTES
Gene-proﬁling studies have indicated that the SW-1353
chondrosarcoma cell line is an appropriate model of IL-1b-
induced protease and NF-kB gene expression in human
chondrocytes23,24. To extend this work, we examined basal
and IL-1b-stimulated MMP-1 gene expression in the SW-
1353 cell line, and in cultured human articular chondrocytes
(HAC) over a 24-h period. IL-1b treatment signiﬁcantly in-
creased MMP-1 mRNA levels in SW-1353 cells and HAC
within 2 h and with a similar magnitude and time course
over 24 h (Fig. 1). Western blot analysis of MMP-1 protein
secreted into the culture media conﬁrmed that IL-1b dramat-
ically increased MMP-1 gene expression after 24 h in both
SW-1353 and HAC. Furthermore, both latent and active
forms of MMP-1 were present in the media of these cells.
These results conﬁrm earlier ﬁndings24 demonstrating that
SW-1353 cells accurately represent IL-1b-induced MMP-1
gene expression in human chondrocytes.
We next examinedNF-kBgene expression in IL-1b treated
chondrocytes to determine how this compared with MMP-1
gene expression. HAC stimulated with IL-1b contained in-
creasingmRNA levels for all three genes over the time period
assayed (Fig. 2). This increase inmRNAwas followed closely
by increases in cellular protein. NF-kB1 consisted of the
105 kDa proform and the 50 kDa processed form in bothuntreated and IL-1b treated cells [Fig. 2(A)]. Dramatic in-
creases of both p105 and p50 were observed in IL-1b stimu-
lated chondrocytes by 8 h of culture. NF-kB2 consisted of the
100 kDa proform and the 52 kDa processed form in both un-
treated and IL-1b treated cells [Fig. 2(B)]. An increase in the
p100 proform was observed in IL-1b treated cells by 8 h of
culture, without a parallel increase in the processed 52 kDa
Fig. 1. IL-1b stimulation of MMP-1 mRNA and protein levels in
chondrocytes. Triplicate conﬂuent cultures of HAC (A) and SW-
1353 cells (B) were placed in serum-free media, both with and with-
out IL-1b (10 ng/ml). Culture medium was collected after 24 h and
assayed for MMP-1 protein by Western blot. Total RNA was
harvested at the indicated time periods and steady state levels of
MMP-1 and GAPDH mRNA were assayed by QRT-PCR. MMP-1
mRNA values were normalized to GAPDH and then plotted as
fold of control. The data presented are representative of two sepa-
rate experiments. *P 0.05.
434 L. Raymond et al.: RelA-dependent MMP-1 expressionFig. 2. IL-1b stimulation of NF-kB gene expression in chondrocytes. Conﬂuent cultures of HAC were placed in serum-free media, both with and
without IL-1b (10 ng/ml). Total cellular RNA and protein were harvested at the indicated time points and assayed by QRT-PCR and Western
blot. Steady state mRNA and protein levels for (A) NF-kB1, (B) NF-kB2 and (C) RelA are presented. All mRNA levels were normalized to
GAPDH and presented as fold of control. The data presented are representative of two separate experiments. *P 0.05.form. Consistent with NF-kB1 and NF-kB2, RelA protein
levels increased in IL-1b stimulated chondrocytes between
8 and 24 h of culture [Fig. 2(C)]. These analyses demonstrate
that IL-1b induces individual NF-kB proteins in chondrocytes
with a time course similar to that ofMMP-1, and suggests that
these proteins may contribute to IL-1b-induced MMP-1 gene
expression in these cells.
IL-1b ACTIVATES THE NF-kB PATHWAY AT TWO
DIFFERENT LEVELS IN CHONDROCYTES
Conﬂicting reports about the requirement of NF-kB for IL-
1b-induced MMP-1 gene expression in chondrocytes20,21
prompted us to address this question in SW-1353 cells.
For these studies, SW-1353 cells were stably transfected
with an expression plasmid for IKBDN, which contains ala-
nine substitutions at serines 32 and 36. These substitutionsrender IKBDN resistant to phosphorylation and degradation
so that it acts as a constitutive repressor of NF-kB nuclear
translocation27e29. IL-1b induction of a transiently trans-
fected kappa B luciferase reporter plasmid was signiﬁcantly
reduced, conﬁrming the functionality of IKBDN [Fig. 3(A)].
Similarly, expression of IKBDN in SW-1353 cells signiﬁ-
cantly reduced IL-1b-induced endogenous MMP-1 mRNA
levels [Fig. 3(B)]. Transfection of SW-1353 cells enhanced
IL-1b-induced MMP-1 expression [compare Figs. 1(B) and
3(B)] and this may reﬂect cellular responses to the expres-
sion of exogenous DNA. Nonetheless, our results agree
with those of Bondeson et al.20, which demonstrate that nu-
clear translocation of RelA-containing NF-kB complexes is
required for optimal IL-1b-induced MMP-1 expression.
We next assayed the ability of IL-1b to activate the NF-kB
pathway over this period. Phosphorylation of IkBa on serine
32 results in ubiquitination and proteosome-mediated
435Osteoarthritis and Cartilage Vol. 15, No. 4Fig. 3. IL-1b stimulation of the NF-kB pathway in chondrocytes. SW-1353 were stably transfected with an empty expression plasmid (CMV) or
a plasmid expressing IKBDN. (A) Stably transfected cells were then transiently transfected with a kappa B luciferase reporter plasmid, placed
in serum-free media both with and without IL-1b for 24 h, and luciferase activity was assayed. Data are from triplicate cultures and are pre-
sented as fold of CMV-transfected, untreated cultures. *P 0.05. (B) Triplicate cultures of the IKBDN line were cultured for 24 h in serum-free
media, both with and without IL-1b. Total RNA was harvested and assayed for MMP-1 and GAPDH by QRT-PCR. Data are presented as fold
of CMV-transfected, untreated cultures. *P 0.05. (C and D) Conﬂuent cultures of HAC were placed in serum-free media, both with and with-
out IL-1b (10 ng/ml). Total cellular protein was harvested at early (C) and late (D) time points and assayed by Western blot for IkBa phospho-
serine 32, total IkBa, RelA phospho-serine 536, total RelA and Actin. The data presented are representative of two separate experiments.degradation of this protein. IL-1b treatment caused phosphor-
ylation of IkBa within 5 min, resulting in degradation of IkBa
protein levels between 5 and 30 min [Fig. 3(C)]. The fact that
phospho-IkBa is readily detectable at 5 min, despite very low
levels of total IkBa at this time point, likely reﬂects the higher
sensitivity of the phospho-speciﬁc antibody. Within 60 min,
IkBa re-synthesis was evident in IL-1b-treated cells
[Fig. 3(C)] and protein levels returned to control levels by 4 h,
despite low levels of IkBa phosphorylation [Fig. 3(D)]. Recent
work by other laboratories has demonstrated that IL-1b stimu-
lation can promote phosphorylation of RelA on serine 536,
which causes RelA to dissociate from IkBa and NF-kB115,30.
To determine if this pathway is activated in chondrocytes, we
treated HAC with IL-1b and assayed RelA phospho-serine
536 at various time points. RelA phospho-serine 536
increased dramatically in IL-1b-treated cells within 5 min de-
spite no increase in total RelA [Fig. 3(C)], and remained above
levels in untreated cells at each time point assayed over 24 h
[Fig. 3(D)].Together, thesedatademonstrate that inaddition to
inducing NF-kB gene expression, IL-1b activates the NF-kB
pathway through a transient degradation of IkBa and a sus-
tained phosphorylation of RelA.
THE EFFECT OF NF-kB GENE SILENCING
ON MMP-1 EXPRESSION
Our data suggest that NF-kB activation, and speciﬁcally
RelA nuclear localization, is required for IL-1b induction ofMMP-1 in chondrocytes. To assess the roles of individual
NF-kB family members during IL-1b-induced MMP-1 gene
expression, we transiently transfected SW-1353 cells with
double-stranded small interfering RNA molecules (siRNA)
and then assayed MMP-1 mRNA levels in untreated and
IL-1b-treated cells. Transfection of speciﬁc siRNA effec-
tively silenced NF-kB1 [Fig. 4(A)], NF-kB2 [Fig. 5(A)] and
RelA [Fig. 6(A)] mRNA and protein in SW-1353 cells treated
with IL-1b for 24 h. Surprisingly, silencing of NF-kB1
[Fig. 4(B)] or NF-kB2 [Fig. 5(B)] in these cells actually in-
creased IL-1b-induced MMP-1 mRNA levels. In contrast, si-
lencing of RelA [Fig. 6(B)] signiﬁcantly reduced basal and
IL-1b-induced MMP-1 mRNA levels in SW-1353 cells. To
ensure that the requirement for RelA is not speciﬁc to the
SW-1353 cell line, we transfected HAC with the same
siRNA and assayed MMP-1 mRNA expression. We found
that while NF-kB1 siRNA had no effect, NF-kB2 siRNA sig-
niﬁcantly increased and RelA siRNA signiﬁcantly reduced,
IL-1-induced MMP-1 mRNA (Fig. 7). These results reem-
phasize that SW-1353 cells are an appropriate model for
primary chondrocytes, and conﬁrm that RelA alone is re-
quired for IL-1-induced MMP-1 gene expression.
In order to determine if the role of RelA in MMP-1 gene
expression is transcriptional, we created a stable line of
SW-1353 cells expressing the luciferase gene under the
transcriptional control of a 3292 nucleotide MMP-1 promoter
fragment. We have recently demonstrated that this pro-
moter construct is IL-1b-responsive in chondrocytes17. We
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siRNA and then assayed luciferase gene expression in un-
treated and IL-1b treated cells (Fig. 8). IL-1b induced lucif-
erase activity in control siRNA-transfected cells, but IL-1b
induction was signiﬁcantly reduced in RelA siRNA-trans-
fected cells. These data demonstrate that silencing of
RelA in chondrocytes reduces IL-1b stimulation of the
MMP-1 promoter. Together, our ﬁndings indicate that IL-
1b activates the NF-kB pathway in chondrocytes through in-
creased NF-kB gene expression, IkBa degradation and
RelA phosphorylation. Furthermore, among the NF-kB
Fig. 4. Gene expression in NF-kB1-silenced SW-1353 cells. Tripli-
cate cultures of SW-1353 cells were transfected with NF-kB1-spe-
ciﬁc siRNA. After 48 h, the cells were placed in serum-free media,
both with and without IL-1b (10 ng/ml) for an additional 24 h. Total
cellular protein and RNA was then harvested and assayed for (A)
NF-kB1 mRNA and protein and (B) MMP-1 mRNA. NF-kB1 and
MMP-1 mRNA levels, as assayed by QRT-PCR, were normalized
to GAPDH mRNA levels in each sample and presented as fold of
control.proteins that can contribute to MMP-1 gene expression,
only RelA is required.
Discussion
The NF-kB pathway controls a variety of cellular re-
sponses through the activation of genes controlling inﬂam-
mation, apoptosis and matrix remodeling. Recent studies
suggest that NF-kB plays a particularly complex role in
the biology of articular chondrocytes. Activation of this
pathway promotes chondrocyte differentiation through
stimulation of Sox9 gene expression31, and IL-1b induc-
tion of NF-kB protects chondrocytes from apoptotic sig-
nals32. We showed previously that Bcl-3, which is
structurally related to IkBa, contributes to IL-1b-induced
MMP-1 gene expression in chondrocytes22,25. Here we
show that concurrent with increasing MMP-1 mRNA
levels, IL-1b stimulation of chondrocytes activates NF-kB
gene expression. Nuclear translocation of RelA-containing
complexes is required for maximal IL-1b-induced MMP-1
expression, and this is mediated through a transient de-
gradation of IkBa and a sustained phosphorylation of
RelA. Moreover, we demonstrate that RelA is absolutely
required for maximal IL-1b induction of MMP-1 mRNA
through activation of the MMP-1 promoter. This work
deﬁnes RelA as a central mediator of IL-1b-induced
MMP-1 gene expression in chondrocytes and establishes
this transcription factor as a potential target for modulating
collagen degradation in arthritis.
Expression of an IKBDN, and silencing of RelA expres-
sion with siRNA, did not completely inhibit IL-1b-induced
MMP-1 gene expression. From these results, one must con-
clude that IL-1b targets signaling pathways in addition to
NF-kB to activate the MMP-1 promoter. In support of this,
we have recently reported that IL-1b activates the ERK
pathway in chondrocytes, leading to MMP-1 transcriptional
activation by CCAAT enhancer binding protein-beta17.
Interestingly, gene silencing NF-kB1 and NF-kB2 in
SW-1353 cells, and NF-kB2 in HAC, actually augmented
IL-1b-induced MMP-1 gene expression. These effects
were not due to a compensatory increase in RelA expres-
sion (data not shown). Both NF-kB1 and NF-kB2 can act
as IkB molecules, because their unprocessed forms pos-
sess ankyrin repeats that can sequester RelA proteins in
the cytoplasm13. In addition, homodimers of processed
NF-kB1 can bind to some kappa B sites and act as tran-
scriptional repressors33. Thus, the dramatic increase of un-
processed NF-kB1 and NF-kB2 proteins present after 8 and
24 h of IL-1b treatment may function to dampen IL-1b-
induced MMP-1 gene expression. Bcl-3, which is an IL-1b
inducible gene in chondrocytes that activates MMP-1 ex-
pression22, can bind to and remove repressive NF-kB1
homodimers from the nucleus33,34. Taken together, these
ﬁndings may explain our observations that Bcl-3 acti-
vates22, while NF-kB1 inhibits, IL-1b-induced MMP-1 gene
expression in SW-1353 cells.
Our ﬁnding that RelA activates MMP-1 independently of
NF-kB1 is supported by the fact that RelA phosphoryla-
tion on serine 536 is elevated in IL-1b stimulated chon-
drocytes over a 24-h period (Fig. 3). Sasaki et al.15
recently reported that this phosphorylation creates
a pool of RelA that translocates to the nucleus because
it does not associate with NF-kB1 or IkBa. Thus, RelA
could promote MMP-1 gene expression even as IkBa
levels return to pre-stimulation levels. Once in the nu-
cleus, RelA phospho-serine 536 is a more potent
437Osteoarthritis and Cartilage Vol. 15, No. 4Fig. 5. Gene expression in NF-kB2-silenced SW-1353 cells. Triplicate cultures of SW-1353 cells were transfected with NF-kB2-speciﬁc siRNA.
After 48 h, the cells were placed in serum-free media, both with and without IL-1b (10 ng/ml), for an additional 24 h. Total cellular protein and
RNA was then harvested and assayed for (A) NF-kB2 mRNA and protein and (B) MMP-1 mRNA. NF-kB2 and MMP-1 mRNA levels, as
assayed by QRT-PCR, were normalized to GAPDH mRNA levels in each sample and presented as fold of control.transactivating protein because it associates more readily
with p30035.
RelA could activate the MMP-1 promoter in IL-1b stimu-
lated chondrocytes through multiple mechanisms. Werecently reported that C/EBPb activates the MMP-1 pro-
moter in IL-1b stimulated chondrocytes17 and RelA cooper-
ates with C/EBPb at several cytokine-responsive
promoters. Using electrophoresis mobility shift assays, we
438 L. Raymond et al.: RelA-dependent MMP-1 expressionFig. 6. Gene expression in RelA-silenced SW-1353 cells. Triplicate cultures of SW-1353 cells were transfected with RelA-speciﬁc siRNA. After
48 h, the cells were placed in serum-free media, both with and without IL-1b (10 ng/ml), for an additional 24 h. Total cellular protein and RNA
was then harvested and assayed for (A) RelA mRNA and protein and (B) MMP-1 mRNA. RelA and MMP-1 mRNA levels, as assayed by QRT-
PCR, were normalized to GAPDH mRNA levels in each sample and presented as fold of control.were unable to detect RelA binding activity at the C/EBPb
site in the MMP-1 promoter. However, RelA could be coop-
erating with C/EBPb through a yet undeﬁned binding site in
the promoter. RelA has also been reported to antagonize
other transcription factors that are established repressorsof MMP-1 transcription. The tumor suppressor p53 re-
presses MMP-1 transcription by disrupting AP-1 interac-
tions with CBP/p30036,37. When RelA is phosphorylated
on serine 536 (as is the case in IL-1b treated chondrocytes),
it inhibits p53 function38 and has the potential to reverse the
439Osteoarthritis and Cartilage Vol. 15, No. 4repressive effects of p53. Similarly, transforming growth fac-
tor beta (TGF-b) represses IL-1b stimulated MMP-1 tran-
scription in dermal ﬁbroblasts through Smad3 and
Smad439. Since RelA interferes with the DNA binding activ-
ity of Smad3 and Smad440, RelA could overcome MMP-1
repression in TGF-b treated cells. Finally, RelA could con-
tribute to MMP-1 gene expression by promoting the expres-
sion of other essential factors. Bcl-3 activates MMP-1 in
IL-1b stimulated chondrocytes22 and expression of constitu-
tively active RelA is sufﬁcient to induce Bcl-3 expression34.
Fig. 8. RelA siRNA targets the MMP-1 promoter. SW1353 cells
were stably transfected with a 3292-nucleotide MMP-1 promoter/lu-
ciferase reporter construct. Triplicate cultures were then transfected
with RelA siRNA, allowed to recover for 48 h and then cultured with
and without IL-1b for 24 h under serum-free conditions. Cultures
were harvested in lysis buffer and assayed for luciferase activity.
*P 0.05.
Fig. 7. MMP-1 gene expression in NF-kB1-, NF-kB2- and RelA-si-
lenced HAC. Triplicate cultures of HAC were transfected with NF-
kB1, NF-kB2 and RelA-speciﬁc siRNA. After 48 h, the cells were
placed in serum-free media, both with and without IL-1b (10 ng/
ml), for an additional 24 h. Total RNA was then harvested and as-
sayed for MMP-1 mRNA by QRT-PCR. MMP-1 mRNA levels were
normalized to GAPDH mRNA levels in each sample and presented
as fold of control. *P 0.05.These few examples demonstrate that RelA has the poten-
tial to activate MMP-1 gene expression at multiple levels,
through direct interactions and through the expression of
other transcription factors.
IL-1b stimulation of MMP-1 gene expression in articular
chondrocytes is a pathway that can contribute directly to
cartilage loss. This gene expression program is extremely
complex and requires a well-orchestrated interplay of multi-
ple protein kinases and transcription factors. The present
study, which deﬁnes the roles of individual components of
the NF-kB pathway, should provide a clearer perspective
toward therapeutic intervention in arthritis.
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